Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats.

AIM To investigate the pharmacological effect of JCM-16021, a Chinese herbal formula, and its underlying mechanisms. METHODS JCM-16021 is composed of seven herbal plant materials. All raw materials of the formula were examined according to the quality control criteria listed in the Chinese Pharmacopeia (2005). In a neonatal maternal separation (NMS) model, male Sprague-Dawley rats were submitted to daily maternal separation from postnatal day 2 to day 14, or no specific handling (NH). Starting from postnatal day 60, rats were administered JCM-16021 (2, 4, 8 g/kg per day) orally twice a day for 28 d. Pain threshold pressure and electromyographic activities of external oblique muscles in response to colorectal distention recorded with a Power Lab System (AD Instruments International), were tested as pain indices. Changes in serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) concentrations in the colon of rats were analyzed; the enterochromaffin cell numbers and serotonin transporter in the colon of rats were also evaluated with an immunohistochemistry method. RESULTS NMS treatment significantly reduced pain threshold pressure (37.4 +/- 1.4 mmHg), as compared to that of NH rats (57.7 +/- 1.9 mmHg, P < 0.05). After JCM-16021 treatment, the pain threshold pressure significantly increased when compared to that before treatment (34.2 +/- 0.9 mmHg vs 52.8 +/- 2.3 mmHg in the high dose group, 40.2 +/- 1.6 mmHg vs 46.5 +/- 1.3 mmHg in the middle dose group, and 39.3 +/- 0.7 mmHg vs 46.5 +/- 1.6 mmHg in the low dose group, P < 0.05). Also JCM-16021 significantly and dose-dependently decreased electromyographic activity to the graded colorectal distension (CRD), (the mean DeltaAUC values were: 0.17 +/- 0.03, 0.53 +/- 0.15, 1.06 +/- 0.18, 1.22 +/- 0.24 in the high dose group; 0.23 +/- 0.04, 0.68 +/- 0.17, 1.27 +/- 0.26, 1.8 +/- 0.3 in the middle dose group; and 0.29 +/- 0.06, 0.8 +/- 0.16, 1.53 +/- 0.24, 2.1 +/- 0.21 in the low dose group for the pressures 20, 40, 60, 80 mmHg), as compared to the NMS vehicle group. The mean DeltaAUC values were: 0.57 +/- 0.12, 1.33 +/- 0.18, 2.57 +/- 0.37, 3.08 +/- 0.37 for the pressures 20, 40, 60, 80 mmHg (P < 0.05). JCM-16021 treatment significantly reduced the 5-HT concentrations (from high, middle and low dosage groups: 60.25 +/- 5.98 ng/100 mg, 60.32 +/- 4.22 ng/100 mg, 73.31 +/- 7.65 ng/100 mg), as compared to the NMS vehicle groups (93.11 +/- 9.85 ng/100 mg, P < 0.05); and increased the 5-HIAA concentrations (after treatment, from high, middle and low dosage groups: 54.24 +/- 3.27 ng/100 mg, 50.34 +/- 1.26 ng/100 mg, 51.37 +/- 2.13 ng/100 mg) when compared to that in the NMS vehicle group (51.75 +/- 1.98 ng/100 mg, P < 0.05); but did not change the enterochromaffin cell numbers in the colon of rats. In addition, NMS rats had higher SERT expression (n = 10) than NH rats (n = 8, P < 0.05). JCM-16021 treatment significantly decreased SERT expression when compared to the NMS group (P < 0.01-0.001). CONCLUSION JCM-16021 can attenuate visceral hypersensitivity, and this analgesic effect may be mediated through the serotonin signaling pathway in the colon of rats.

[1]  Z. Bian,et al.  Intracolonical administration of protease-activated receptor-2 agonists produced visceral hyperalgesia by up-regulating serotonin in the colon of rats. , 2009, European journal of pharmacology.

[2]  T. Dinan,et al.  Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[3]  Z. Bian,et al.  The analgesic effect of paeoniflorin on neonatal maternal separation-induced visceral hyperalgesia in rats. , 2008, The journal of pain : official journal of the American Pain Society.

[4]  Jin-yan Luo,et al.  Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. , 2007, World journal of gastroenterology.

[5]  Z. Bian,et al.  Neonatal maternal separation enhances central sensitivity to noxious colorectal distention in rat , 2007, Brain Research.

[6]  W. Leung,et al.  Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[7]  R. Spiller,et al.  Mechanisms of hypersensitivity in IBS and functional disorders , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[8]  Justin C.Y. Wu,et al.  Herbal medicine versus hyosine in the treatment of irritable bowel syndrome: a double-blinded randomized study , 2007 .

[9]  J. Tack,et al.  REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders , 2007 .

[10]  M. Coates,et al.  Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[11]  X. Tian,et al.  Electro-acupuncture attenuates stress-induced defecation in rats with chronic visceral hypersensitivity via serotonergic pathway , 2006, Brain Research.

[12]  M. Coates,et al.  Review article: intestinal serotonin signalling in irritable bowel syndrome , 2006, Alimentary pharmacology & therapeutics.

[13]  K. Tillisch,et al.  Diagnosis and treatment of irritable bowel syndrome: State of the art , 2005, Current gastroenterology reports.

[14]  M. Fanselow,et al.  Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[15]  M. Farthing.  Treatment of irritable bowel syndrome , 1981, BMJ : British Medical Journal.

[16]  M. Crowell,et al.  Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. , 2004, Gastroenterology.

[17]  M. Crowell,et al.  Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. , 2004, Current opinion in investigational drugs.

[18]  R. Spiller,et al.  Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. , 2003, Gastroenterology.

[19]  A. Lembo,et al.  Irritable bowel syndrome: evaluation and treatment. , 2003, Gastroenterology clinics of North America.

[20]  A. Viera,et al.  Management of irritable bowel syndrome. , 2002, American family physician.

[21]  M. Camilleri.  Serotonergic modulation of visceral sensation: lower gut , 2002, Gut.

[22]  P. Plotsky,et al.  Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[23]  H. Echizen,et al.  Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS) May Have Elevated Serotonin Concentrations in Colonic Mucosa as Compared with Diarrhea-Predominant Patients and Subjects with Normal Bowel Habits , 2001, Digestion.

[24]  C. Nemeroff,et al.  Long-term behavioral and neuroendocrine adaptations to adverse early experience. , 2000, Progress in brain research.

[25]  R. Spiller,et al.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome , 2000, Gut.

[26]  P. Pasricha,et al.  A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. , 2000, Gastroenterology.

[27]  M. Gershon.  Review article: roles played by 5‐hydroxytryptamine in the physiology of the bowel , 1999, Alimentary pharmacology & therapeutics.

[28]  F. Sundler,et al.  Endocrine cells in human intestine: an immunocytochemical study. , 1983, Gastroenterology.